COVID-19 Clinical Trials

Showing 801-820 of 1,603 trials

Study to Evaluate the Effects of AT-527 in Non-Hospitalized Adult Patients With Mild or Moderate COVID-19

NCT04709835

This randomized study evaluates the antiviral activity, safety, efficacy and pharmacokinetics of AT-527 versus a placebo in participants with mild or moderate coronavirus disease (COVID-19) who are not hospitalized.

COVID-19

Hoffmann-La Roche104 participantsStarted Feb 2021

Hamilton, Ontario, Canada • Athens, Greece • Nikaia Attikis, Greece +9 more locations

COMPLETEDPHASE1/PHASE2

Safety and Immunogenicity Study in Adults of AZD1222 and rAd26-S Administered as Heterologous Prime Boost Regimen for the Prevention of Coronavirus Disease 2019 (COVID-19)

NCT04760730

This is a Phase I/II, parallel group, single blinded (participant blinded), randomised study assessing the immunogenicity and safety of AZD1222 and rAd26-S administered as heterologous prime-boost in alternating order in 2 study groups for the Prevention of COVID-19.

COVID-19

R-Pharm100 participantsStarted Jul 2021

Al Ain City, United Arab Emirates

Study to Evaluate the Effects of AT-527 in Non-Hospitalized Adult Patients With Mild or Moderate COVID-19

Safety and Immunogenicity Study in Adults of AZD1222 and rAd26-S Administered as Heterologous Prime Boost Regimen for the Prevention of Coronavirus Disease 2019 (COVID-19)

Related Searches

Validating an ELISpot for Early Detection of an Active Immune Response Against COVID-19

Myeloid Cells in Patients With Covid-19 Pneumonia

Extrapulmonary Presentations of COVID-19 Patients

Efficacy, Safety, Tolerability of AXA1125 in Fatigue After COVID-19 Infection

AnaConDa-therapy in COVID-19 Patients

Nebulized Heparin for COVID19-associated Acute Respiratory Failure

Evaluation of Equine Antibody Treatment in Patients With COVID 19 Infection

Elderberry for Immune Support

Expanded Access to Convalescent Plasma for Treatment of COVID-19

Impact of COVID-19 Pandemic on Hepatopancreatobiliary Surgical Services in Singapore

Study to Evaluate the Safety and Efficacy of High Dose Intravenous Immune Globulin (IVIG) Plus Standard Medical Treatment (SMT) Versus SMT Alone in Participants in Intensive Care Unit (ICU) With Coronavirus Disease (COVID-19)

Effect of Sars-cov-2 on Donor Oocyte Quality and Quantity, a Multicenter Retrospective Study.

Neonatal SARS-CoV-2 Anti-spike Protein Receptor-binding Domain Antibodies at Delivery

Lymphatic Osteopathic Manipulative Medicine to Enhance Coronavirus (COVID-19) Vaccination Efficacy

Analysis of Clinical Characteristics of Hemodialysis Patients With Omicron Infection

Recovery of Patients From COVID-19 After Critical Illness

COVID-19 Staff Testing of Antibody Responses Study (Co-Stars)

Sociodemographic, Clinical, Quality of Life and Health Care Conditions in COVID-19 Survivors.